You are here

  • Home
  • Archive
  • Volume 60, Issue 5
  • Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis

Article info

Article menu
Download PDFPDF
Extended report
Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis

Authors

  • L Vasiliauskiene aDepartment of Immunology, Experimental and Clinical Medicine Institute, Vilnius, Lithuania, bDepartment of Autoimmunology, Statens Serum Institut, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • A Wiik aDepartment of Immunology, Experimental and Clinical Medicine Institute, Vilnius, Lithuania, bDepartment of Autoimmunology, Statens Serum Institut, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  • M Høier-Madsen aDepartment of Immunology, Experimental and Clinical Medicine Institute, Vilnius, Lithuania, bDepartment of Autoimmunology, Statens Serum Institut, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  1. Dr A Wiik, Department of Autoimmunology, Statens Serum Institut, Artillerivej 5, DK-2300 Copenhagen S, Denmarkaw{at}ssi.dk
View Full Text

Citation

Vasiliauskiene L, Wiik A, Høier-Madsen M
Prevalence and clinical significance of antikeratin antibodies and other serological markers in Lithuanian patients with rheumatoid arthritis
Annals of the Rheumatic Diseases 2001;60:459-466.

Publication history

  • Accepted November 17, 2000
  • First published May 1, 2001.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Annals of the Rheumatic Diseases